The Access to Medicine Index, a ranking of pharmaceutical companies' work to distribute medications to low- and middle-income countries, just named Johnson & Johnson #3 on its biennial list, underscoring the company's deep history of ensuring people in underserved communities receive the treatments they need.
A potential COVID-19 vaccine. Passionate efforts toward achieving racial and social justice. Smarter, more sustainable product packaging. These are just a few of the resolutions company change makers are aiming to bring to light this year—and they're already hard at work on them.
Tracking the spread of the virus in real time. Analyzing data to learn more about who's most vulnerable. These are just a couple of ways the company's data science team is helping inform how to respond to the pandemic.
As the J.P. Morgan Healthcare Conference takes place this week, the President of Johnson & Johnson Innovation – JJDC, Inc. shares some of the scientific breakthroughs and collaborations his team is championing to help address the unmet needs and well-being of people around the world.
With its Phase 3 clinical trial now fully enrolled, the Global Head of Research & Development at Janssen brings us up to speed on the progress of the company's vaccine candidate, including upcoming key milestones.
Cold temps and dry air can wreak havoc on already stressed skin. For those with certain inflammatory skin diseases, Lloyd S. Miller, M.D., Ph.D., says following a personalized treatment plan is the key to finding more comfort this season.
It's one of the world's deadliest infectious diseases, killing more people each year than HIV/AIDS and malaria combined. As 2020 comes to a close, we're taking a look back at the strides the company has made in fighting this preventable illness to help bring us closer to a tuberculosis-free world.
From Fast Company's 2020 Best Workplaces for Innovators to Interbrand's Best Global Brands of 2020, learn about some of the distinctions that the company has been honored with this year for its work to help people and communities around the world.
The novel coronavirus has exposed deeply rooted disparities across the healthcare system which disproportionately impact communities of color. The way to begin to pave the way for lasting change? Inclusive innovation, community outreach and policy work—and a passion for fighting for an equitable future.
For the 35th year in a row, Johnson & Johnson has been named to Working Mother's 100 Best Companies list—and these two employees were named Working Mother and Working Dad of the Year for their incredible strength in the face of adversity.
Emmanuelle Charpentier, Ph.D., and Jennifer Doudna, Ph.D., were just honored with the prestigious award for their work with gene-editing technology CRISPR. But they also have a connection to Johnson & Johnson—they were awarded the Dr. Paul Janssen Award in 2014. Learn more about what makes them so impressive.
When you're the CFO of a company, you have a holistic view of how a pandemic can touch every aspect of a business, especially when it's a healthcare company. So we posed inquiring mind questions to Joe Wolk about what the past eight months have been like for him at the financial helm of the company—via a Zoom interview.